12:00 AM
 | 
May 24, 2010
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 5/21 cls
Cardiome Pharma Corp. (TSX:COM; NASDAQ:CR\ME) Dundee David Martin Rating change Buy (from under review) -3% C$7.99
Martin raised his target to C$10 from C$8...

Read the full 325 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >